John Simard

John Simard

Former President & Chief Executive OfficeratXBiotech· In proxies 2022–2025

Pay in FY2023+19% from the year before · XBiotech stock +14.0% the same year

John Simard was paid $5.6M in FY2023 (Dec), up 19%. XBiotech stock rose 14.0% that year.

Pay$100 in the stock at the end of FY21 → $36
Pay is from the Summary Compensation Table of each XBiotech proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. XBiotechPublic company · 4 yr
    • Former President & Chief Executive Officer2022 – Present · 4 yrStock in role -82%
  2. Company’s Board of DirectorsPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?